G
Gad Getz
Researcher at Broad Institute
Publications - 627
Citations - 309042
Gad Getz is an academic researcher from Broad Institute. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 189, co-authored 520 publications receiving 247560 citations. Previous affiliations of Gad Getz include University of Colorado Denver & University of California, San Diego.
Papers
More filters
Journal ArticleDOI
Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy,Chip Stewart,Andrew Dunford,Jaegil Kim,Atanas Kamburov,Robert A. Redd,Michael S. Lawrence,Michael S. Lawrence,Margaretha G.M. Roemer,Amy Li,Marita Ziepert,Annette M. Staiger,Jeremiah Wala,Matthew D. Ducar,Ignaty Leshchiner,Ester Rheinbay,Amaro Taylor-Weiner,Caroline A. Coughlin,Julian M. Hess,Chandra Sekhar Pedamallu,Dimitri Livitz,Daniel Rosebrock,Mara Rosenberg,Adam Tracy,Heike Horn,Paul Van Hummelen,Andrew L. Feldman,Brian K. Link,Anne J. Novak,James R. Cerhan,Thomas M. Habermann,Reiner Siebert,Andreas Rosenwald,Aaron R. Thorner,Matthew Meyerson,Matthew Meyerson,Todd R. Golub,Todd R. Golub,Rameen Beroukhim,Rameen Beroukhim,Gerald Wulf,German Ott,Scott J. Rodig,Scott J. Rodig,Stefano Monti,Donna Neuberg,Markus Loeffler,Michael Pfreundschuh,Lorenz Trümper,Gad Getz,Gad Getz,Margaret A. Shipp +51 more
TL;DR: In the version of this article originally published, some text above the “Tri–nucleotide sequence motifs” label in Fig. 2a appeared incorrectly and the text was garbled and should have appeared as nucleotide codes.
Journal ArticleDOI
Comprehensive characterization of 412 muscle invasive urothelial carcinomas: Final analysis of The Cancer Genome Atlas (TCGA) project.
Seth P. Lerner,Jaegil Kim,David J. Kwiatkowski,Gad Getz,John N. Weinstein,Andrew D. Cherniack,Guangwu Guo,Rehan Akbani,Katherine A. Hoadley,William Y. Kim,Gordon Robertson,Andrew J. Mungall,Toshinori Hinoue,Peter W. Laird,Hikmat Al-Ahmadie,Jonathan E. Rosenberg,Joaquim Bellmunt,Dean F. Bajorin,Donna E. Hansel,Chad J. Creighton +19 more
TL;DR: The integrated molecular analysis of 131 tumors in 2014 and the entire cohort of 412 tumors from the TCGA project in chemotherapy-naive muscle invasive urothelial bladder cancer are reported on, finding TP53 remained the most commonly mutated gene.
Proceedings ArticleDOI
Abstract 139: Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
Nicholas J. Haradhvala,Oksana Zavidij,Tarek H. Mouhieddine,Romanos Sklavenitis-Pistofidis,Jihye Park,Mairead Reidy,Abdallah Flaifel,Benjamin Ferland,Salomon Manier,Mark Bustoros,Daisy Huynh,Marzia Capelletti,Brianna Berrios,Mahshid Rahmat,Chia Jen Liu,Meng Xiao He,Esteban Braggio,Rafael Fonseca,Yosef E. Maruvka,Jennifer L. Guerriero,Melissa Goldman,Eliezer M. Van Allen,Steven A. McCarroll,Jamil Azzi,Gad Getz,Irene M. Ghobrial +25 more
TL;DR: The immune response beginning in premalignant conditions is demonstrated to be heterogeneous, including compromised antigen presentation as well as alterations in cellular composition and signaling, which may prove valuable in determination of progression risk and open up potential strategies for therapy.
Proceedings ArticleDOI
Abstract P5-01-03: Ultrasensitive detection of minimal residual disease in patients treated for breast cancer
Heather A. Parsons,Justin Rhoades,Sarah C. Reed,Greg Gydush,Priyanka Ram,Pedro Exman,Kan Xiong,Christopher Lo,Tianyu Li,Mark Fleharty,Greg Kirkner,Denisse Rotem,Ofir Cohen,Melissa E. Hughes,Shoshanna Rosenberg,Laura C. Collins,Kathy D. Miller,Brendan Blumenstiel,Carrie Cibulskis,Donna Neuberg,Samuel S. Freeman,Niall J. Lennon,Nikhil Wagle,Gavin Ha,Daniel G. Stover,Atish D. Choudhury,Gad Getz,Matthew Meyerson,Nan Lin,Ian E. Krop,J. Christopher Love,G. Mike Makrigiorgos,Ann H. Partridge,Erika Mayer,Todd R. Golub,Viktor A. Adalsteinsson +35 more
TL;DR: A novel approach to MRD tracking based on the premise that tracking many - rather than one or a handful of - mutations inherently increases sensitivity and that assay personalization maximizes sensitivity in a disease without multiple, recurrent mutations is presented.
Journal ArticleDOI
P-021: 7C6 is a novel monoclonal antibody that induces enhanced anti-myeloma activity of cytokine induced memory-like (CIML) NK cells by blocking MICA/B shedding and antibodydependent cell cytotoxicity
Sabrin Tahri,Nang Kham Su,L. Lampe,Han Dong,Juliana Vergara Cadavid,Natalie Papazian,Amanda Cao,Jean-Baptiste Alberge,Lucas Ferrari de Andrade,Mahshid Rahmat,Yu J. Shen,Rebecca Boiarsky,Laura Blanco,Bruno Castro de Paiva,Andreas Günther,Gad Getz,Pieter Sonneveld,Kai W. Wucherpfennig,Tom Cupedo,Irene M. Ghobrial,Romee Rizwan +20 more